Last Updated:
Name Designation Appointment Date Status
Yogesh Mansukhlal Pitroda

Appointed as Director since March 2006

Director 20-Mar-2006 Current
Premium access

Complete director details

Unlock the complete director and KMP records available for Steigen Pharmaceuticals Private Limited.

  • Complete appointment and designation records
  • Current and past company associations
  • Shareholding and remuneration where filed

Verified entity values are shown only after access is granted.

Bharat Kirankumar Shah

Appointed as Director since March 2006

Director 10-Mar-2006 Current
Rajnikant Kanaiyalal Kava

Appointed as Director since March 2006

Director 20-Mar-2006 Current

People Timeline

Explore the timeline of key personnel in Steigen Pharmaceuticals Private Limited's leadership journey.

Loading...
Contact Details
  • Address Plot No.4 & 5, Shah Industrialestate Near Range Office, Gokhivare, Vasai-E, T, Hane., Wef- 26.4.2000. Maharashtra, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code
  • Country India
  • Website -
Frequently Asked Questions
You can contact Steigen Pharmaceuticals Private Limited through their registered address at Plot No.4 & 5, Shah Industrialestate Near Range Office, Gokhivare, Vasai-E, T, Hane., Wef- 26.4.2000. Maharashtra, India, or via their website if available. Social media links are also provided where applicable.
The current directors of Steigen Pharmaceuticals Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • YOGESH MANSUKHLAL PITRODA
  • BHARAT KIRANKUMAR SHAH
  • RAJNIKANT KANAIYALAL KAVA
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available